MedElevator Войти в исследования
← Поиск публикаций

DOI 10.7417/ct.2026.2045

Медицинская библиотека · La Clinica terapeutica · 2026

Serum Neurotensin Levels in Vitiligo Patients: A Comparative Study with Correlation to Disease Activity and Severity. A Case-Control Study.

Elnemr Mohamed, Alwaseef Mohammad Abd Elhameed, Abdelbaset Nora El Saeed, Hashem Esraa Mahmoud Awaad Ahmed, Amer Azza Samy Mohamed, Yehia Fatima G, Emam Loai, Omar Abdulmabod, Rashad Sara M, Solit Samar Mohamed, Tolba Aziza Elsayed, Mohamed Eman Elsayed, Afifi Esam, Ismail Amal Ahmed, Elshafey Ola Hamdy Ahmed, Azzam Ahmed Ayman, Eltrafi Narmen Hamadelnil Ibrahim, Bukas Samantha Georgette, Bashtar Mohamed, Tahoun Sara A, Saleh Rania Mostafa

СтатьяСравнительное исследованиеНаблюдательное исследованиеПеревод в очереди

Аннотация

BACKGROUND

Vitiligo is a chronic depigmentary disorder with autoimmune and neurogenic mechanisms. Neurotensin, a neuropeptide with immunomodulatory properties, has been implicated in inflammatory skin conditions, but its role in vitiligo remains unclear.

OBJECTIVES

To compare serum neurotensin levels in active and stable vitiligo patients versus healthy controls, and to evaluate their correlation with disease activity (VIDA score) and extent (VASI score).

METHODS

A case-control study was conducted including 40 vitiligo patients (20 active, 20 stable) and 20 age- and sex-matched healthy controls. Serum neurotensin was measured using ELISA. Disease activity and extent were assessed with VIDA and VASI scores, respectively. Statistical analysis included Kruskal-Wallis, Mann-Whitney U, and Spearman rank correlation tests.

RESULTS

The median serum neurotensin levels were 20.40 ng/ml (range 7.35-74.00) in active patients, 14.55 ng/ml (range 6.10-30.00) with stable patients and 11.20 ng/ml (range 6.40-18.30) with controls. Kruskal-Wallis test indicated that there was a statistically significant overall difference between the three groups (H=16.506, p<0.001). Serum neurotensin showed a modest but statistically significant positive correlation with VIDA score (rs = 0.333, p = 0.036), but no significant correlation with VASI score (p = 0.190).

CONCLUSIONS

Serum neurotensin is elevated in vitiligo, particularly in active disease, supporting a potential role for neurogenic mechanisms in melanocyte destruction. Its association with disease activity suggests its potential utility as a biomarker of vitiligo activity.

Для цитирования: Elnemr Mohamed, Alwaseef Mohammad Abd Elhameed, Abdelbaset Nora El Saeed, Hashem Esraa Mahmoud Awaad Ahmed, Amer Azza Samy Mohamed, Yehia Fatima G, Emam Loai, Omar Abdulmabod, Rashad Sara M, Solit Samar Mohamed, Tolba Aziza Elsayed, Mohamed Eman Elsayed, Afifi Esam, Ismail Amal Ahmed, Elshafey Ola Hamdy Ahmed, Azzam Ahmed Ayman, Eltrafi Narmen Hamadelnil Ibrahim, Bukas Samantha Georgette, Bashtar Mohamed, Tahoun Sara A, Saleh Rania Mostafa. Serum Neurotensin Levels in Vitiligo Patients: A Comparative Study with Correlation to Disease Activity and Severity. A Case-Control Study.. La Clinica terapeutica. 2026. DOI: 10.7417/ct.2026.2045.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.